Cell surface expression and metabolism of major histocompatibility complex class II invariant chain (CD74) by diverse cell lines
about
Macrophage CD74 contributes to MIF-induced pulmonary inflammationFurther evidence for increased macrophage migration inhibitory factor expression in prostate cancer.Enhanced expression of CD74 in gastrointestinal cancers and benign tissuesPhase I study of the anti-CD74 monoclonal antibody milatuzumab (hLL1) in patients with previously treated B-cell lymphomasHelicobacter pylori binds to CD74 on gastric epithelial cells and stimulates interleukin-8 productionEpstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2.The Helicobacter pylori urease B subunit binds to CD74 on gastric epithelial cells and induces NF-kappaB activation and interleukin-8 production.CD74 interferes with the expression of fas receptor on the surface of lymphoma cellsRole of macrophage migration inhibitory factor (MIF) in pollen-induced allergic conjunctivitis and pollen dermatitis in mice.The development of potential antibody-based therapies for myelomaCD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.The anti-CD74 humanized monoclonal antibody, milatuzumab, which targets the invariant chain of MHC II complexes, alters B-cell proliferation, migration, and adhesion molecule expression.Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-γ.Antibodies to CD20 and MHC class II antigen bound to B-lymphoma cells accumulate in shed cytoplasmic fragments.Target Therapy in Hematological Malignances: New Monoclonal Antibodies.Milatuzumab - a promising new immunotherapeutic agent.Porcine CD74 is involved in the inflammatory response activated by nuclear factor kappa B during porcine circovirus type 2 (PCV-2) infection.CD74 is a survival receptor on colon epithelial cells.T Cells Regulate Peripheral Naive Mature B Cell Survival by Cell-Cell Contact Mediated through SLAMF6 and SAP.Bioinformatics analysis of gene expression alterations conferring drug resistance in tumor samples from melanoma patients with EGFR-activating BRAF mutations.Transport of MHC II:Ii complex to plasma membraneInsertion of MHC II:Ii complex in to the plasma membranePhase I, multicentre, dose-escalation trial of monotherapy with milatuzumab (humanized anti-CD74 monoclonal antibody) in relapsed or refractory multiple myeloma.
P2860
Q24644589-B4916C0F-69C6-4FF1-9F21-780A09154A5CQ24813097-4564DE9F-8571-4E1E-8D19-70998516263CQ30433510-0B6B1FF9-454D-4797-B563-2F968B457D93Q33421020-F1336CAB-330D-4621-A57D-74F8476A80A4Q33769048-9C2968A4-E40E-4B77-A4DF-76E70548BB23Q34116845-6E093F2E-7CB6-4469-B555-997FD44AE473Q34334270-CC050D75-127B-4A50-A671-2636202AFDD7Q34409837-8492E55D-7706-46C9-99D5-6408240C7D33Q35043911-6A60A925-6AB5-438E-8CE6-A2B03C06F08AQ35788245-3CD5C1A9-D3E9-429A-80E2-2C246F6ED9ADQ35958283-D7E9AFC7-3F4D-486F-AE4D-3957BD4D9EFFQ36245707-5BF6D6D2-FAF2-43F5-8348-93EF7F873940Q36269050-AA074747-BE15-43C8-9666-7331A32EFB9CQ36695767-5E596CB4-C5F3-4856-AB06-298DC031F0AFQ36979140-5D8A32D4-79B0-4D10-8B8C-EE1B820B6606Q37646791-D23D169A-AAB0-4D7D-B949-067D71CB60A5Q39143909-804F90E8-808A-4CB4-820D-BCD7F6E7D4D5Q39682893-27D0F6C4-0527-4BBF-9C83-89D0F4A9B5F1Q47806755-5A41E2B2-029A-4444-9C03-06DF8C005556Q49232945-D5004A62-0CE4-4411-9789-2226610C6047Q50291584-DF15A1D0-41A2-4BA8-8F87-B98FB3BF6A4FQ50291585-2D3B9600-0EE5-4EEF-952A-44568631002EQ50765392-5F982036-7439-4315-8D0D-5D9BBF37C2A7
P2860
Cell surface expression and metabolism of major histocompatibility complex class II invariant chain (CD74) by diverse cell lines
description
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1999
@ast
scientific journal article
@en
vedecký článok (publikovaný 1999/10/01)
@sk
vědecký článek publikovaný v roce 1999
@cs
wetenschappelijk artikel (gepubliceerd op 1999/10/01)
@nl
наукова стаття, опублікована в жовтні 1999
@uk
مقالة علمية (نشرت في أكتوبر 1999)
@ar
name
Cell surface expression and me ...... n (CD74) by diverse cell lines
@ast
Cell surface expression and me ...... n (CD74) by diverse cell lines
@en
Cell surface expression and me ...... n (CD74) by diverse cell lines
@nl
type
label
Cell surface expression and me ...... n (CD74) by diverse cell lines
@ast
Cell surface expression and me ...... n (CD74) by diverse cell lines
@en
Cell surface expression and me ...... n (CD74) by diverse cell lines
@nl
prefLabel
Cell surface expression and me ...... n (CD74) by diverse cell lines
@ast
Cell surface expression and me ...... n (CD74) by diverse cell lines
@en
Cell surface expression and me ...... n (CD74) by diverse cell lines
@nl
P2093
P2860
P1433
P1476
Cell surface expression and me ...... n (CD74) by diverse cell lines
@en
P2093
D. M. Goldenberg
H. J. Hansen
M. J. Mattes
P2860
P304
P356
10.1046/J.1365-2567.1999.00868.X
P577
1999-10-01T00:00:00Z